Declaration on the health risks of silicone implants

Declaration on the health risks of silicone implants

The European Parliament,,

- having regard to the content of Petitions Nos 470/98 and 771/98,

- having regard to the fact that since 1992 silicone implants can only be used in the USA when there are special medical needs and having regard to the ban on silicone implants adopted in France in 1995 and to the moratorium on their marketing and use adopted in Canada in 1992,

- having regard to the study drawn up by the US Federal Food and Drug Administration (FDA), the study drawn up by STOA in May 2000 on 'Health risks posed by silicone implants in general, with special attention to breast implants' and to the opinion of the Committee on the Environment of 11 October 2000,

- whereas every day more women are deciding to have this operation without having received full information on the health risks, after-effects and subsequent costs of it,

1. Urges the Council and Commission to adopt a moratorium on the marketing and use of silicone-gel filled breast implants, at least for a time until new provisions exist based on Option 3 of the STOA report;

2. Calls on the Council and the Commission to ensure the adoption and implementation of critical specific measures to improve information for patients, tracking and surveillance, quality control and assurance and key research and to take note of the recommendations made by the Committee on the Environment on 11 October 2000;

3. Instructs its President to forward this resolution to the Council and the Commission.

europarl.eu.int

Tweet